A Phase II Randomized Trial of Docetaxel Based Induction Chemotherapy in Patients with N2/N3 Locally Advanced Head and Neck Cancer
|Effective start/end date||11/3/04 → 6/30/14|
- ROSALIND FRANKLIN UNIV OF MED & SCI
- AVENTIS PHARM PRODUCTS INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.